1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics, November 2019

Healthcare Analysis & Statistics, November 2019

1-30 of about 200 reports

Market Spotlight: Sarcoma (Copy)

Market Spotlight: Sarcoma (Copy)

  • $ 16500
  • Industry report
  • April 2018

This Market Spotlight report covers the Sarcoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease incidence forecast, ...

  • Industries : Cancer, Pathology
  • Countries : World
Chronic Heart Failure Pricing, Reimbursement, and Access

Chronic Heart Failure Pricing, Reimbursement, and Access

  • $ 7500
  • Industry report
  • April 2018

Overview Payers were originally extremely worried about the potential cost burden of Entresto, however, the level of concern surrounding the drug is currently moderate as physician uptake has been lowe ...

  • Industries : Health Services
  • Countries : United States, European Union, Europe
Market Spotlight: Primary Sclerosing Cholangitis

Market Spotlight: Primary Sclerosing Cholangitis

  • $ 16500
  • Industry report
  • April 2018

This Market Spotlight report covers the Primary Sclerosing Cholangitis market, comprising disease background, treatment overview, key pipeline drugs, clinical trials, and a 10-year global disease prevalence ...

  • Industries : Pathology
  • Countries : World, United States
Chronic Kidney Disease Market and Forecast Analyst to 2035

Chronic Kidney Disease Market and Forecast Analyst to 2035

  • $ 22000
  • Industry report
  • April 2018

Disease Overview Chronic kidney disease is a progressive condition affecting over 10% of the world’s population, and is characterized by kidney damage and impaired kidney function. Processes involved ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, Japan, European Union
NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

  • $ 22000
  • Industry report
  • April 2018

Follicular lymphoma (FL) is an indolent subtype of non-Hodgkin’s lymphoma (NHL). It is the second most common type of NHL after diffuse large B-cell lymphoma (DLBCL), and accounts for more than 20% of ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
HIV Disease Coverage Forecast and Market Analysis to 2024

HIV Disease Coverage Forecast and Market Analysis to 2024

  • $ 22000
  • Industry report
  • April 2018

DISEASE OVERVIEW The human immunodeficiency virus, or HIV, is a retrovirus that infects the cells of the immune system such as T lymphocytes, specifically cluster of differentiation-4+ T cells, dendritic ...

  • Industries : Pathology
  • Countries : United States, European Union
Market Spotlight: Sarcoma

Market Spotlight: Sarcoma

  • $ 16500
  • Industry report
  • April 2018

This Market Spotlight report covers the Sarcoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease incidence forecast, ...

  • Industries : Cancer, Pathology
  • Countries : World
NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034

  • $ 22000
  • Industry report
  • April 2018

Mantle cell lymphoma (MCL) is a rare form of B-cell non-Hodgkin’s lymphoma (NHL), accounting for 3–6% of new NHL cases. The term MCL derives from the growth pattern of the lymphoma, with tumor cells ...

  • Industries : Cancer, Pathology
  • Countries : European Union, United States, Japan
NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034

  • $ 22000
  • Industry report
  • April 2018

Diffuse large B-cell lymphoma (DLBCL) is a form of hematological malignancy that affects B lymphocytes. This cancer is the most common type of non-Hodgkin’s lymphoma (NHL), accounting for about one-third ...

  • Industries : Cancer, Pathology, Medical Biotechnology
  • Countries : United States, Japan, European Union
Abilify/Abilify Maintena

Abilify/Abilify Maintena

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Abilify (aripiprazole; Otsuka/Lundbeck) is an atypical antipsychotic that contains aripiprazole, a partial agonist of dopamine receptor D2 and serotonin receptor 5-HT1A, and antagonist of ...

  • Industries : Mental Health, Pathology
  • Countries : United States, European Union, Japan
Drug Overview: Zyprexa

Drug Overview: Zyprexa

  • $ 10000
  • Industry report
  • April 2018

Drug OverviewZyprexa (Eli Lilly) contains the atypical antipsychotic olanzapine, which acts as an antagonist at the D2 and 5-HT2A receptors. Zyprexa was initially launched in September 1996 for the treatment ...

  • Industries : Mental Health, Pathology
  • Countries : United States, Japan, European Union
Drug Overview: Risperdal Consta

Drug Overview: Risperdal Consta

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Risperdal Consta (Johnson&Johnson) contains risperidone, an atypical antipsychotic that acts as a selective dopamine and serotonin receptor antagonist that also blocks the dopamine D2, serotonin ...

  • Industries : Mental Health, Pathology
  • Countries : United States, European Union, Japan
Bipolar Disorder Disease Coverage to 2024

Bipolar Disorder Disease Coverage to 2024

  • $ 22000
  • Industry report
  • April 2018

Disease Overview Bipolar disorder is a psychiatric disorder characterized by unusual shifts in mood, energy, activity levels, and the ability to carry out everyday tasks. Patients with the disorder may ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : United States, Japan, European Union
Drug Overview: Lamictal and Lamictal XR

Drug Overview: Lamictal and Lamictal XR

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Lamictal (GlaxoSmithKline) contains lamotrigine, a phenyltriazine antiepileptic drug that acts at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibits the release ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Seroquel/Seroquel XR

Seroquel/Seroquel XR

  • $ 10000
  • Industry report
  • April 2018

Drug Overview The Seroquel franchise contains quetiapine, which acts as an antagonist at multiple neurotransmitter receptors in the brain, such as serotonin 5-HT1A and 5-HT2, dopamine D1 and D2, histamine ...

  • Industries : Mental Health, Pathology
  • Countries : United States, Japan, European Union
Drug Overview: Geodon

Drug Overview: Geodon

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Geodon contains ziprasidone, a dopamine (D2) and serotonin (5-HT2) antagonist developed and marketed by Pfizer. Geodon initially launched in the US in 2001 for the treatment of schizophrenia. ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : Japan, United States
Drug Overview: Saphris

Drug Overview: Saphris

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Saphris (Allergan/Lundbeck/Meiji Seika) contains the atypical antipsychotic asenapine, which acts as a dopamine D2 and serotonin 5-HT2A antagonist. The drug was originally developed by Organon ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Drug Overview: lumateperone

Drug Overview: lumateperone

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Lumateperone is a novel, orally available antipsychotic being developed by Intra-Cellular Therapies for several neuropsychiatric disorders. Lumateperone acts as a serotonin 5-HT2A recepto ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Drug Overview: ALKS 3831

Drug Overview: ALKS 3831

  • $ 10000
  • Industry report
  • April 2018

Drug OverviewALKS 3831 is an orally available, fixed-dose combination of samidorphan (ALKS 33) and olanzapine being developed by Alkermes. Samidorphan is a novel, potent mu-opioid antagonist, while olanzapine ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : United States
Drug Overview: Vraylar

Drug Overview: Vraylar

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Vraylar (cariprazine; Gedeon Richter/Allergan/Mitsubishi Tanabe) is a novel atypical antipsychotic with partial agonistic activity at D2 and D3 receptors, and selectivity for the D3 receptor. ...

  • Industries : Mental Health, Pathology
  • Countries : United States, European Union
Drug Overview: Latuda

Drug Overview: Latuda

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Latuda (lurasidone; Sumitomo Dainippon/Angelini) contains the atypical antipsychotic lurasidone, which acts as an antagonist of dopamine receptors D2, and serotonin receptors 5-HT2A. By ...

  • Industries : Mental Health, Pathology
  • Countries : United Kingdom, Italy, Japan, European Union, United States, Germany, Spain
Drug Overview: Rexulti

Drug Overview: Rexulti

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Rexulti (brexpiprazole) is Otsuka’s latest atypical antipsychotic, approved simultaneously in the US for schizophrenia and major depressive disorder in July 2015. The drug acts similarly ...

  • Industries : Mental Health, Pathology
  • Countries : United States, Japan, European Union
Market Spotlight: Eating Disorders

Market Spotlight: Eating Disorders

  • $ 16500
  • Industry report
  • April 2018

This Market Spotlight report covers the Eating Disorders market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, patent information, a 10-year disease prevalence forecast, ...

  • Industries : Mental Health, Pathology
  • Countries : World
2018 Biomedtracker / Meddevicetracker / Datamonitor Healthcare Post-ACC Report

2018 Biomedtracker / Meddevicetracker / Datamonitor Healthcare Post-ACC Report

  • $ 599
  • Industry report
  • April 2018

The American College of Cardiology (ACC) 67th Scientific Session was held in Orlando, FL from 10–12 March 2018.  The highlight of this year’s conference was results from Praluent’s (REGN, SNY) ODYSSEY ...

  • Industries : Chronic Disease
Market Spotlight: Benign Prostatic Hyperplasia

Market Spotlight: Benign Prostatic Hyperplasia

  • $ 16500
  • Industry report
  • April 2018

This Market Spotlight report covers the Benign Prostatic Hyperplasia market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease ...

  • Industries : Pathology
  • Countries : World, United States
Market Spotlight: Amyloidosis

Market Spotlight: Amyloidosis

  • $ 16500
  • Industry report
  • April 2018

This Market Spotlight report covers the amyloidosis market, comprising key marketed and pipeline drugs, key upcoming events, patent information, a 10-year disease incidence forecast, and licensing and ...

  • Industries : Pathology, Drug Development
  • Countries : United States, World
Market Spotlight: Peripheral T-Cell Lymphoma (PTCL)

Market Spotlight: Peripheral T-Cell Lymphoma (PTCL)

  • $ 16500
  • Industry report
  • March 2018

This Market Spotlight report covers the Peripheral T-Cell Lymphoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, patent information, a 10-year disease incidence ...

  • Industries : Cancer, Pathology
  • Countries : World
Market Spotlight: Norovirus, Datamonitor Healthcare

Market Spotlight: Norovirus, Datamonitor Healthcare

  • $ 16500
  • Industry report
  • March 2018

This Market Spotlight report covers the Norovirus market, comprising key pipeline drugs, clinical trials, and an epidemiological overview.  Key Takeaways Worldwide, about one out of every five cases ...

  • Industries : Pathology
  • Countries : United States, World
Market Spotlight: Tumor Lysis Syndrome (TLS)

Market Spotlight: Tumor Lysis Syndrome (TLS)

  • $ 16500
  • Industry report
  • March 2018

This Market Spotlight report covers the Tumor Lysis Syndrome (TLS) market, comprising key marketed and pipeline drugs, clinical trials, patent information, and a 10-year disease incidence forecast, as ...

  • Industries : Cancer
  • Countries : World, United States
Market Spotlight: Esophageal Cancer

Market Spotlight: Esophageal Cancer

  • $ 16500
  • Industry report
  • March 2018

This Market Spotlight report covers the esophageal cancer market, comprising key marketed and pipeline drugs, patent information, a 10-year disease incidence forecast, and licensing and acquisition deals. ...

  • Industries : Cancer, Pathology
  • Countries : United States

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on